BIO Protocol 擴展到 Solana，瞄準 DeSci 市場，融資 3,300 萬美元

BIO Protocol 是幣安實驗室支持的去中心化科學 (DeSci) 項目，正在擴展到 Solana。利用 Solana 的可擴展性和低廉費用，此舉可能會徹底改變 DeSci 市場。

BIO Protocol, a decentralized science (DeSci) project backed by Binance Labs, is set to expand its operations to Solana. This move, capitalizing on Solana's scalability and low transaction fees, could revolutionize the DeSci market. Backed by $33 million in funding, BIO Protocol aims to transform the funding and commercialization of early-stage scientific research.

BIO Protocol 是一個由 Binance Labs 支持的去中心化科學 (DeSci) 項目，計劃將其業務擴展到 Solana。這項措施利用了 Solana 的可擴展性和低交易費用，可能會徹底改變 DeSci 市場。 BIO Protocol 獲得 3,300 萬美元的資金支持，旨在改變早期科學研究的資助和商業化。

Currently operating on Ethereum with seven "BioDAOs," BIO Protocol is expanding its presence by integrating with Solana and other blockchains. This launch marks a significant step in highlighting the growing potential of Solana's ecosystem in driving innovation within the DeSci domain.

BIO Protocol 目前在以太坊上運行，擁有七個“BioDAO”，正在透過與 Solana 和其他區塊鏈整合來擴大其影響力。此次發布標誌著 Solana 生態系統在推動 DeSci 領域創新方面不斷增長的潛力邁出了重要一步。

The protocol is engaged in researching cryopreservation, women's health, and psychedelics for mental health. It plans to expand its research initiatives to cover chronic diseases and COVID. Notably, BIO Protocol's founder and CEO, Paul Kohlhaas, announced the Solana launch on X, hinting at potential airdrops to major pharmaceutical companies.

該協議致力於研究冷凍保存、婦女健康和心理健康迷幻藥。它計劃擴大研究範圍，涵蓋慢性病和新冠肺炎。值得注意的是，BIO Protocol 的創辦人兼執行長 Paul Kohlhaas 宣佈在 X 上推出 Solana，暗示可能會向主要製藥公司進行空投。

Moreover, BIO Protocol will be participating in the upcoming JP Morgan Healthcare Conference, showcasing the increasing convergence between digital assets and healthcare.

此外，BIO Protocol 將參加即將舉行的摩根大通醫療保健會議，展示數位資產與醫療保健之間的日益整合。

The DeSci sector is currently valued at $1.18 billion, with $185.6 million of tokens traded in the past 24 hours. Among the top DeSci tokens are OriginTrail (TRAC), VitaDAO (VITA), ResearchCoin (RSC), Hippocrat (HPO), and AxonDAO Governance Token (AXGT).

DeSci 產業目前估值為 11.8 億美元，過去 24 小時內交易了 1.856 億美元的代幣。頂級 DeSci 代幣包括 OriginTrail (TRAC)、VitaDAO (VITA)、ResearchCoin (RSC)、Hippocrat (HPO) 和 AxonDAO 治理代幣 (AXGT)。

VITA and RSC have seen an impressive surge in the past seven days, with gains of 61% and 33%, respectively. In contrast, TRAC and AXGT faced declines of 11.4% and 5.7%, respectively. Other DeSci projects also experienced a downturn last week, with Urolithin A ($URO) falling 20.6% and Rifampicin ($RIF) crashing 13.6%. However, $RIF shot up 50% in the past 24 hours.

VITA和RSC在過去7天裡出現了令人印象深刻的飆升，漲幅分別為61%和33%。相比之下，TRAC 和 AXGT 分別下跌 11.4% 和 5.7%。其他 DeSci 項目上週也經歷了低迷，尿石素 A ($URO) 下跌 20.6%，利福平 ($RIF) 暴跌 13.6%。然而，$RIF 在過去 24 小時內飆升了 50%。

This article's content is solely intended for informational and educational purposes and does not constitute financial advice or any other form of advice. Coin Edition and its team are not liable for any losses incurred as a consequence of utilizing the content, products, or services covered in the article. Before taking any actions pertaining to the company, readers are advised to conduct their own thorough research and consult a qualified financial adviser.

本文內容僅供參考和教育目的，並不構成財務建議或任何其他形式的建議。 Coin Edition 及其團隊對因使用本文所述內容、產品或服務而造成的任何損失不承擔任何責任。在採取與公司有關的任何行動之前，建議讀者進行徹底的研究並諮詢合格的財務顧問。